Phosphomannomutase 2 Congenital Disorder of Glycosylation
1 clinical trials · Condition
◉ Watch Phosphomannomutase 2 Congenital Disorder of Glycosylation
| Record | Firm | Date |
|---|---|---|
| Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG (NCT04925960) | Maggie's Pearl, LLC | 2022-11-10 |
Track Phosphomannomutase 2 Congenital Disorder of Glycosylation automatically
Every clearance here is in the API, with alerts when new ones post.